Dynamic changes of high-sensitivity troponin T concentration during infancy: Clinical implications.


Journal

Physiological research
ISSN: 1802-9973
Titre abrégé: Physiol Res
Pays: Czech Republic
ID NLM: 9112413

Informations de publication

Date de publication:
17 03 2021
Historique:
pubmed: 18 1 2021
medline: 15 12 2021
entrez: 17 1 2021
Statut: ppublish

Résumé

Cardiac troponin T determination plays a dominant role in diagnosis of myocardial pathologies. Despite generally accepted use of high-sensitive cardiac troponin T assays (hscTnT) and clearly defined cut-off limit in adults, the uncertainty persists in infants. The aim of this study was to assess plasmatic concentrations of hscTnT and describe sequential age-related dynamic changes of hscTnT in healthy infants and toddlers. Seventy-eight children (52 males/26 females) from Czech Republic aged 44 to 872 days (median, interquartile range 271; 126 to 486 days) were consecutively enrolled in the single-center, prospective observational study. Plasma concentrations of hscTnT were analyzed by the electrochemiluminescent method, age-related reference intervals were calculated using the polynominal regression model. Amongst the study population (n=78), the upper limit of hscTnT concentration defined as the 99th percentile was calculated. The 99th percentile with 95 % confidence interval at the end of 2nd, 3rd, 4th, 5th, 6th and 7th month of postnatal life were: 81 (40.6 to 63.6), 61 (36.0 to 55.3), 47 (31.9 to 48.3), 37 (28.1 to 42.3), 30 (24.7 to 37.2) and 25 (21.5 to 32.7) ng/l, respectively. Concentration of adults 99th percentile (14 ng/l) was achieved approximately at 1 year of postnatal life. Statistically significant negative correlation of hscTnT concentration with age (r=-0.81, p<0.001) was found. Significant gender differences were not found (p>0.07). The study revealed substantially increased reference intervals of hscTnT levels in infants when compared with adult population. Based on our preliminary results, the age-related interpretation of hscTnT plasmatic concentration is recommended.

Identifiants

pubmed: 33453718
pii: 934453
doi: 10.33549/physiolres.934453
pmc: PMC8820510

Substances chimiques

Biomarkers 0
Troponin T 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

27-32

Références

Pediatr Cardiol. 2019 Dec;40(8):1645-1654
pubmed: 31489446
Clin Biochem. 2004 Dec;37(12):1079-82
pubmed: 15589813
Pediatr Cardiol. 2006 Jul-Aug;27(4):396-401
pubmed: 16830088
Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1446-51
pubmed: 23302686
Clin Chem. 1991 Aug;37(8):1405-11
pubmed: 1868602
Physiol Res. 2018 May 4;67(2):191-195
pubmed: 29303610
Clin Chem. 2014 Aug;60(8):1098-104
pubmed: 24842954
Arch Dis Child Fetal Neonatal Ed. 2001 Jan;84(1):F34-7
pubmed: 11124921
Int J Angiol. 2007 Summer;16(2):53-8
pubmed: 22477272
Cardiovasc Ultrasound. 2015 Mar 21;13:13
pubmed: 25889047
Clin Chem. 2019 Apr;65(4):589-591
pubmed: 30737206
Am J Cardiol. 1991 Jun 15;67(16):1360-7
pubmed: 1904190
Clin Chem. 2009 Jul;55(7):1303-6
pubmed: 19478023
Physiol Res. 1995;44(2):99-104
pubmed: 8789321
Clin Chim Acta. 2016 Jul 1;458:68-71
pubmed: 27118089
J Am Heart Assoc. 2016 Jun 27;5(6):
pubmed: 27353610
Acta Paediatr. 2007 Feb;96(2):181-4
pubmed: 17429901

Auteurs

P Jehlicka (P)

Charles University in Prague, Faculty of Medicine in Pilsen, Faculty Hospital, Department of Paediatrics, Pilsen, Czech Republic. jehlicka@fnplzen.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH